Editorial: Can Hepatitis B Core-Related Antigen Be the New Biomarker for Hepatocellular Carcinoma in Nucleoside Analogue-Treated Chronic Hepatitis B? Author’s Reply
Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.15156
Full Text
Open PDFAbstract
Available in full text
Date
March 13, 2019
Authors
Publisher
Wiley